Clinical and Biological Characteristics of Hidradenitis Suppurativa
NCT03967600 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000
Last updated 2026-05-04
Summary
Hidradenitis suppurativa (HS) is a common and debilitating skin disease that is poorly understood and understudied. As a result, little is known about disease prognosis and few effective treatments exist for this condition. This prospective observational cohort study aims to comprehensively characterize the clinical and biological features of HS. The results of this research will provide a basis for the development of an HS clinical classification system and identification of potential treatments for HS.
Conditions
Sponsors & Collaborators
-
University of California, San Francisco
lead OTHER
Principal Investigators
-
Haley B Naik, MD, MHSc, FAAD · University of California, San Francisco
Eligibility
- Min Age
- 13 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2016-07-15
- Primary Completion
- 2026-07-15
- Completion
- 2026-07-15
Countries
- United States
Study Locations
More Related Trials
-
Defects of Keratinocytes Function in Dermatologic Patients
NCT06324552 ·Status: RECRUITING
-
Interest of a Systematic Biopsy for Hard-to-heal Leg Ulcers
NCT00709631 ·Status: COMPLETED
-
Predictive and Prognostic Biomarkers in Patients With Mycosis Fungoides and Sézary Syndrome.
NCT04904146 ·Status: RECRUITING
-
Identification of Cutaneous and Blood Biomarkers Predictive of Response to Systemic Treatments During Chronic Inflammatory Skin Diseases
NCT06599411 ·Status: NOT_YET_RECRUITING
-
Identifying Factors Influencing In-Hospital Relapse in Pemphigus Patients
NCT06167408 ·Status: COMPLETED
-
Identifying Skin Biopsy Sites
NCT01632644 ·Status: COMPLETED
-
Pilonidal Sinus-Turkey
NCT05519033 ·Status: COMPLETED
-
Molecular Evaluation of TAAR1 and JAK/STAT Pathway in Hidradenitis Suppurativa
NCT07278011 ·Status: COMPLETED
-
Research in Skin Inflammation
NCT00026741 ·Status: COMPLETED
-
SKIN Disease Profiling by an Exploratory, pRospective, Biomarker Study in dermatoloGY Practice (SKINERGY)
NCT07021495 ·Status: RECRUITING
-
Autoimmune Blistering Diseases Study
NCT02753777 ·Status: RECRUITING
-
Effectiveness of Bosentan Therapy in Patients With Systemic scleRosis and Progressive Digital ulcEr Disease.
NCT05168215 ·Status: RECRUITING
-
Characteristics and the Future of the City Chilblains
NCT03101761 ·Status: COMPLETED
-
The Gut and Skin Microbiome in Vitiligo Disease Progression
NCT03577327 ·Status: RECRUITING
-
Baricitinib in the Treatment of Adults With Pyoderma Gangrenosum (PG)
NCT04901325 ·Status: COMPLETED ·Phase: PHASE2
-
Identification of Vulnerability Factors in the Course of Pemphigus Patients
NCT02237313 ·Status: COMPLETED ·Phase: NA
-
Study of Molecular Markers in Cutaneous Inflammation Between Psoriatic Lesional Skin and Healthy Non-lesional Skin
NCT03423004 ·Status: COMPLETED ·Phase: NA
-
Study of Inflammatory Mechanisms in Epidermolysis Bullosa Simplex- Dowling Meara
NCT01556308 ·Status: COMPLETED ·Phase: NA
-
Retrospective Study of the Effects of Sub-pathologic Phenotypes of BP on Clinical Management and Prognosis
NCT06213909 ·Status: RECRUITING
-
Genetic and Other Aspects of Podoconiosis
NCT01939431 ·Status: TERMINATED
-
Study on the Clinical Features, Comorbidities and Pathologies Associated With Pyoderma Gangrenosum
NCT03636737 ·Status: UNKNOWN
-
Study of Skin Tumors in Tuberous Sclerosis
NCT00001975 ·Status: RECRUITING
-
Linking Epidermal Barrier Function With Anti-Oxidant Defense Mechanisms in Skin Conditions
NCT03198390 ·Status: TERMINATED
-
Longitudinal Spatial Frequency Domain Imaging Study
NCT05672992 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
A Non-interventional Study to Describe the Dupilumab Long-term Treatment, Safety and Patient Reported Outcomes in Chronic Nodular Prurigo (Prurigo Nodularis) in Clinical Routine
NCT06087627 ·Status: RECRUITING